You are here: Industry Insights > Drug

News List

Prices Will Soon Be Included in TV Drug Ads drugs
May 09, 2019
Prices Will Soon Be Included in TV Drug Ads.
Daiichi Sankyo Announces [Fam-] Trastuzumab Deruxtecan Demonstrated Clinically Meaningful Response in Patients with Refractory HER2 Positive Metastatic Breast Cancer, a Population with High Unmet Need prnewswire
May 08, 2019
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) and AstraZeneca announced positive topline results for the pivotal phase 2 DESTINY-Breast01 trial of [fam-] trastuzumab deruxtecan (DS-8201).
Ruzurgii Feature Drug approved for autoimmune disorder in kids of specified ages fda
May 08, 2019
The U.S. Food and Drug Administration approved Ruzurgi (amifampridine) tablets for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in patients 6 to less than 17 years of age.
Report shows US brand-name drug prices ‘highest in the world’ europeanpharmaceuticalreview
May 08, 2019
A new study has found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the US compared with other countries.
Health Highlights drugs
May 08, 2019
The number of legally prescribed opioid pain drugs stolen by health care workers in the United States rose 126% between 2017 and 2018, a new report says.
Aesica adds development capability with new purpose built facility europeanpharmaceuticalreview
May 07, 2019
Product life cycle services expanded, including for high potent and controlled drugs…
EU approval for Regeneron and Sanofi’s rheumatoid arthritis drug europeanpharmaceuticalreview
May 07, 2019
The European Commission (EC) has granted marketing authorisation for Regeneron and Sanofi’s Kevzara (sarilumab) for the treatment of rheumatoid arthritis…
NICE approves 3 drugs for treating plaque psoriasis in children europeanpharmaceuticalreview
May 07, 2019
NICE has approved adalimumab (Humira, AbbVie), etanercept (Enbrel, Pfizer) and ustekinumab (Stelara, Janssen) for treating plaque psoriasis in children…
Good news for AZ's 'next phase of growth': Its cancer drugs have shifted into high gear fiercepharma
May 06, 2019
For the first time, AstraZeneca's top-selling medicine isn't a stomach drug or a respiratory inhaler or any other primary care med. It's a cancer drug.
ALA-artemisinin combination therapy for cancer identified europeanpharmaceuticalreview
May 06, 2019
Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment…

Previous page 1 2 3 4 5 6 7 8 9 10 ... 49 50 Next page